About: Small molecules targeting viral RNA

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Small molecules targeting viral RNA Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Small molecules targeting viral RNA
Creator	Hermann, Thomas
Source	Medline; PMC
abstract	Highly conserved noncoding RNA (ncRNA) elements in viral genomes and transcripts offer new opportunities to expand the repertoire of drug targets for the development of antiinfective therapy. Ligands binding to ncRNA architectures are able to affect interactions, structural stability or conformational changes and thereby block processes essential for viral replication. Proof of concept for targeting functional RNA by small molecule inhibitors has been demonstrated for multiple viruses with RNA genomes. Strategies to identify antiviral compounds as inhibitors of ncRNA are increasingly emphasizing consideration of drug‐like properties of candidate molecules emerging from screening and ligand design. Recent efforts of antiviral lead discovery for RNA targets have provided drug‐like small molecules that inhibit viral replication and include inhibitors of human immunodeficiency virus (HIV), hepatitis C virus (HCV), severe respiratory syndrome coronavirus (SARS CoV), and influenza A virus. While target selectivity remains a challenge for the discovery of useful RNA‐binding compounds, a better understanding is emerging of properties that define RNA targets amenable for inhibition by small molecule ligands. Insight from successful approaches of targeting viral ncRNA in HIV, HCV, SARS CoV, and influenza A will provide a basis for the future exploration of RNA targets for therapeutic intervention in other viral pathogens which create urgent, unmet medical needs. Viruses for which targeting ncRNA components in the genome or transcripts may be promising include insect‐borne flaviviruses (Dengue, Zika, and West Nile) and filoviruses (Ebola and Marburg). WIREs RNA 2016, 7:726–743. doi: 10.1002/wrna.1373 1.. RNA Structure and Dynamics > Influence of RNA Structure in Biological Systems; 2.. RNA Interactions with Proteins and Other Molecules > Small Molecule–RNA Interactions; 3.. Regulatory RNAs/RNAi/Riboswitches > Regulatory RNAs.
has issue date	2016-06-16(xsd:dateTime)
bibo:doi	10.1002/wrna.1373
bibo:pmid	27307213
has license	no-cc
sha1sum (hex)	80caa1024c946576659b17c70053a78eff011632
schema:url	https://doi.org/10.1002/wrna.1373
resource representing a document's title	Small molecules targeting viral RNA
has PubMed Central identifier	PMC7169885
has PubMed identifier	27307213
schema:publication	Wiley Interdiscip Rev RNA
resource representing a document's body	covid:80caa1024c946576659b17c70053a78eff011632#body_text
is schema:about of	named entity 'drug targets' named entity 'inhibit' named entity 'therapy' named entity 'genomes' named entity 'Viruses' named entity 'drug-like' named entity 'coronavirus' named entity 'development' named entity 'viral' named entity 'CHANGES' named entity 'STRATEGIES' named entity 'SYNDROME' named entity 'SMALL MOLECULES' named entity 'compounds' named entity 'viral replication' named entity 'selectivity' named entity 'RNA' named entity 'ncRNA' named entity 'antiviral' named entity 'small molecule' named entity 'transcripts' named entity 'concept' named entity 'antiviral' named entity 'discovery' named entity 'ligands' named entity 'noncoding RNA' named entity 'ncRNA' named entity 'essential' named entity 'Zika' named entity 'SARS CoV' named entity 'Viruses' named entity 'HCV' named entity 'drug targets' named entity 'Ligands' named entity 'Marburg' named entity 'viral replication' named entity 'viral replication' named entity 'small molecule' named entity 'insect-borne' named entity 'small molecules' named entity 'flaviviruses' named entity 'Small molecules' named entity 'mass spectrometry' named entity 'RNA' named entity 'HIV' named entity 'RNA secondary structure' named entity 'host cell' named entity 'methoxy' named entity 'translational frameshifting' named entity 'cis' named entity 'cell-based' named entity 'ligand' named entity 'Gly' named entity 'oligonucleotide' named entity 'HBV' named entity 'metabolite' named entity 'HCV IRES' named entity 'ligand' named entity 'small molecules' named entity 'UTR' named entity 'initiation factors' named entity 'reading frames' named entity 'emetine' named entity 'ribosomal frameshifting' named entity 'structural studies' named entity 'HCV' named entity 'RNA' named entity 'regulatory elements' named entity 'HCV IRES' named entity 'logarithm' named entity 'drug target' named entity 'internal ribosome entry site' named entity 'RNAs' named entity 'motif' named entity 'RNA' named entity 'stacking interactions' named entity 'biological activity' named entity 'H1 receptor antagonist' named entity 'motif' named entity 'purine' named entity 'transcription elongation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software